PharmaCielo Ltd. (TSXV: PCLO)

PharmaCielo Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14	30	26	146	289	298
Market Cap Growth	-5.95%	12.06%	-81.83%	-49.48%	-3.28%	-
Enterprise Value	35	46	38	143	287	279
Last Close Price	0.09	0.18	0.17	0.98	2.08	3.05
Forward PE	-	-	-	-	5.23	7.50
PS Ratio	5.52	19.26	4.99	74.96	108.74	379.17
PB Ratio	-4.02	-17.68	4.15	7.54	10.99	6.56
P/TBV Ratio	-	-	4.15	7.54	11.05	6.83
EV/Sales Ratio	13.59	30.14	7.08	73.75	108.01	354.65
Debt / Equity Ratio	-2.75	-10.90	1.97	0.44	0.17	0.03
Asset Turnover	0.11	0.07	0.17	0.05	0.06	0.01
Inventory Turnover	1.26	1.31	1.94	3.46	3.66	0.08
Quick Ratio	0.07	0.04	0.25	0.77	0.87	4.72
Current Ratio	0.15	0.16	0.58	1.14	1.04	5.95
Return on Equity (ROE)	-	-691.70%	-112.89%	-116.87%	-122.03%	-63.78%
Return on Assets (ROA)	-16.00%	-26.48%	-22.67%	-39.16%	-55.52%	-32.96%
Return on Capital (ROIC)	-22.55%	-35.25%	-29.63%	-53.56%	-67.28%	-34.80%
Earnings Yield	-97.82%	-54.89%	-54.78%	-18.27%	-15.16%	-11.62%
FCF Yield	-21.39%	-17.40%	-39.24%	-14.55%	-9.70%	-11.83%
Buyback Yield / Dilution	-7.73%	-6.03%	-3.67%	-29.41%	-17.17%	-22.84%
Total Shareholder Return	-7.73%	-6.03%	-3.67%	-29.41%	-17.17%	-22.84%

Source: S&P Capital IQ. Standard template. Financial Sources.